Pathogenesis of Hematologic Malignancies



Status:Enrolling by invitation
Conditions:Other Indications, Blood Cancer, Blood Cancer, Lymphoma, Hematology, Hematology
Therapuetic Areas:Hematology, Oncology, Other
Healthy:No
Age Range:1 - Any
Updated:6/20/2018
Start Date:September 2008
End Date:October 2020

Use our guide to learn which trials are right for you!

Pathogenesis of Acute Leukemia, Lymphoproliferative Disorders, and Myeloproliferative Disorders

The cause of blood and bone marrow cancers is poorly understood; however, most research
focuses on how cancer cells grow and develop. Because the causes of these cancers are
unknown, current treatments may be unnecessarily harsh and often do not provide a cure.
Identifying the causes of blood cancers would allow for the development of treatments that
are more likely to provide a cure. To find the causes of blood and bone marrow cancers, we
will look for specific cancer cell abnormalities that are responsible for cancer cell growth.
We will then look to see if drugs that can reverse these abnormalities can kill cancer cells.


Inclusion Criteria:

- Suspected or confirmed diagnosis of AL, LPD, MDS, or MPD

- Male or female of all ages

- Willing and able to sign informed consent

- Willing guardian consent for participants under 18 years of age

Exclusion Criteria:

- No suspected or confirmed diagnosis of acute leukemias (AL), lymphoproliferative
disorders (LPD), myelodysplastic syndromes (MDS), or myeloproliferative diseases (MPD)
We found this trial at
1
site
3181 S.W. Sam Jackson Park Road
Portland, Oregon 97239
503 494-7999
OHSU Knight Cancer Institute OHSU Knight Cancer Institute is known worldwide for our contributions to...
?
mi
from
Portland, OR
Click here to add this to my saved trials